Howard Capital Management (New York)’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Howard Capital Management (New York)'s AMGN Position: Q4 2020 in Review
Howard Capital Management (New York) increased its Amgen (AMGN) stake by 0.41% in Q4 2020, buying an estimated $4.84K and bringing the position to 5,165 shares worth $1.19M. The position accounts for 0.13% of the portfolio, ranked #47.
Howard Capital Management (New York) first reported a position in AMGN in Q4 2013 and has held it in 29 quarters since. The position peaked at $1.48M in Q4 2019. 2,218 funds tracked by Wall St. Rank hold AMGN as of Q4 2020.
- Howard Capital Management (New York) held 5,165 shares of Amgen worth $1.19M as of Q4 2020.
- Howard Capital Management (New York) bought 21 Amgen shares in Q4 2020, an estimated $4.84K.
- Amgen made up 0.13% of Howard Capital Management (New York)'s portfolio in Q4 2020, its #47 holding.
- Howard Capital Management (New York) first reported a position in Amgen in Q4 2013 and has held it in 29 quarters since.
- Howard Capital Management (New York)'s Amgen position peaked at $1.48M in Q4 2019.
- 2,218 funds tracked by Wall St. Rank held Amgen as of Q4 2020.
Based on Howard Capital Management (New York)'s 13F filing for Q4 2020, filed 2 Feb 2021.